Kidney Fibrosis In Vitro and In Vivo Models: Path Toward Physiologically Relevant Humanized Models
Advanced Healthcare Materials · 2025-04 · 14 (9)
DOI: 10.1002/adhm.202403230 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advanced Healthcare Materials, online erschienen am 05.02.2025. Verfasst von Gabriele Addario und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Complex Tissue Regeneration, MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, ER Maastricht, 6229,…. Hauptthemen laut MEDLINE: Kidney, Models, Biological, Renal Insufficiency, Chronic. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 209 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Dutch Kidney Foundation, H2020 Marie Skłodowska-Curie Actions, Nierstichting.
Abstract (Originalsprache)
Chronic kidney disease (CKD) affects over 10% of the global population and is a leading cause of mortality. Kidney fibrosis, a key endpoint of CKD, disrupts nephron tubule anatomy and filtration function, and disease pathomechanisms are not fully understood. Kidney fibrosis is currently investigated with in vivo models, that gradually support the identification of possible mechanisms of fibrosis, but with limited translational research, as they do not fully recapitulate human kidney physiology, metabolism, and molecular pathways. In vitro 2D cell culture models are currently used, as a starting point in disease modeling and pharmacology, however, they lack the 3D kidney architecture complexity and functions. The failure of several therapies and drugs in clinical trials highlights the urgent need for advanced 3D in vitro models. This review discusses the urinary system's anatomy, associated diseases, and diagnostic methods, including biomarker analysis and tissue biopsy. It evaluates 2D and in vivo models, highlighting their limitations. The review explores the state‐of‐the‐art 3D‐humanized in vitro models, such as 3D cell aggregates, on‐chip models, biofabrication techniques, and hybrid models, which aim to mimic kidney morphogenesis and functions. These advanced models hold promise for translating new therapies and drugs for kidney fibrosis into clinics.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Complex Tissue Regeneration, MERLN Institute for Technology-Inspired Regenerative Medicine, Maastricht University, ER Maastricht, 6229, The Netherlands.
ORCID-Profile: Carlos Mota
Förderung
- Dutch Kidney Foundation
- H2020 Marie Skłodowska-Curie Actions
- Nierstichting
Zitieren
APA
Addario, G., Moroni, L., & Mota, C. (2025). Kidney Fibrosis In Vitro and In Vivo Models: Path Toward Physiologically Relevant Humanized Models. Advanced Healthcare Materials, 14(9). https://doi.org/10.1002/adhm.202403230
Vancouver
Addario G, Moroni L, Mota C. Kidney Fibrosis In Vitro and In Vivo Models: Path Toward Physiologically Relevant Humanized Models. Advanced Healthcare Materials. 2025;14(9). doi:10.1002/adhm.202403230
BibTeX
@article{Addario2025,
author = {Addario, Gabriele and Moroni, Lorenzo and Mota, Carlos},
title = {Kidney Fibrosis In Vitro and In Vivo Models: Path Toward Physiologically Relevant Humanized Models},
journal = {Advanced Healthcare Materials},
year = {2025},
volume = {14},
number = {9},
doi = {10.1002/adhm.202403230}
}
EUVIMED